论文部分内容阅读
目的探讨酒石酸美托洛尔治疗慢性心力衰竭的临床疗效。方法将60例慢性心力衰竭患者其随机分为观察组和对照组各30例,对照组给予常规治疗,如休息、吸氧、低盐饮食、给予钙离子阻滞剂、抗感染、强心剂、利尿剂、抗心律失常药等,观察组在对照组的基础上给予酒石酸美托洛尔治疗。结果观察组的总有效率为96.67%,明显高于对照组的76.67%,差异具有统计学意义(P<0.05)。两组均无明显不良反应发生。结论酒石酸美托洛尔治疗慢性心力衰竭疗效显著,可明显改善患者的心功能以及临床症状,提高患者的生活质量,值得临床推广使用。
Objective To investigate the clinical efficacy of Metoprolol tartrate in the treatment of chronic heart failure. Methods Sixty patients with chronic heart failure were randomly divided into observation group (30 cases) and control group (30 cases). The control group was given routine treatment such as rest, oxygen inhalation, low salt diet, calcium blockers, antiinfective, cardiotonic, diuretic Agents, anti-arrhythmic drugs, the observation group was given metoprolol tartrate based on the control group. Results The total effective rate of the observation group was 96.67%, which was significantly higher than 76.67% of the control group, the difference was statistically significant (P <0.05). No significant adverse reactions occurred in both groups. Conclusion Metoprolol tartrate treatment of chronic heart failure significant effect, can significantly improve the patient’s cardiac function and clinical symptoms, improve the quality of life of patients, it is worth promoting the use of the clinic.